ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

Strengthening DNA to Prevent Inflammation, Heart Disease, Dementia and More

Magnesium: Widespread Deficiency with Deadly Consequences

Turmeric compound boosts regeneration of brain stem cells

The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol

Culprits of Autism Identified: Toxins, Gut Bacteria, Nutritional Deficiencies, and Vaccines Made wit...

CoQ10: The Longevity Factor

Omega-3 Fatty Acids Increase Brain Volume

Optimal Prostate Defense Requires a Multi-Modal Strategy

Use of Broad-Spectrum Antibiotics Before Age 2 Associated with Obesity Risk

Extending Life and Fighting Disease with Resveratrol

 
Print Page
Email Article

A metagenomic approach to investigate the microbial causes of myalgic encephalomyelitis/chronic fatigue syndrome: moving beyond XMRV

  [ 6 votes ]   [ Discuss This Article ]
By Ruth R. Miller et al. • www.ProHealth.com • October 20, 2013


A metagenomic approach to investigate the microbial causes of myalgic encephalomyelitis/chronic fatigue syndrome: moving beyond XMRV. Image credit: FreeDigitalPhotos.net by chrisroll
Image credit: FreeDigitalPhotos.net by chrisroll

By Ruth R. Miller et al.

EDITORIAL

Three years ago, a novel association between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the murine retrovirus XMRV was published.[1] Since then, 191 papers have been published on the subject (NCBI PubMed, accessed 6 November 2012), largely disproving the initial association, a trend confirmed by a recent multicentre blinded trial which definitively concluded that there is no association between ME/CFS and XMRV.[2] It is therefore time to revisit the investigation of ME/CFS aetiology. Metagenomics offers a promising new opportunity for hypothesis discovery in microbial associations with ME/CFS, and we describe herein the technical basis of this approach and its advantages in aetiological agent investigation.

Metagenomics: a brief primer

Metagenomics is the analysis of all nucleic acid recovered directly from a clinical or environmental sample. Using next-generation sequencing platforms, researchers can sequence the DNA of an entire sample, generating multiple short sequences known as “reads.” Computational techniques can then be used to identify the microbes present in the sample (the “microbiome”) and their relative abundance. Improvements in sequencing platforms have brought the cost of a typical metagenomics sample to under $200, resulting in an increasing number of metagenomics-based analyses in the literature. A complete microbial census of various body sites was performed on 250 human volunteers as part of the Human Microbiome Project,[3] while subsequent “metagenome-wide association studies” (MGWAS) have compared the microbiomes of healthy individuals to those with various conditions. Amongst other findings, these data have identified associations between inflammatory bowel disease and enterobacteriaceae,[4] colorectal carcinoma and fusobacterium,[5] and type two diabetes and butyrate-producing bacteria.[6]

Metagenomics for ME/CFS

Metagenomics offers an unbiased opportunity to investigate potential novel associations between microbes and ME/CFS. Unlike previous studies, which have examined the host immune response, response to antimicrobial treatment regimens, or used PCR-based screening, a metagenomics protocol replaces the reductionist search for a specific agent with a more holistic discovery-oriented strategy capable of revealing associations with new candidate aetiological agents, including novel pathogens. Metagenomics also offers several other advantages relative to other experimental approaches, summarised in Table 1. These include technical advantages, such as the elimination of a culture step and the ability to detect low-abundance microorganisms. More general opportunities include the ability to investigate the role of microbial communities and/or functional networks in ME/CFS as opposed to an individual species.

The metagenomics approach is also unique in that even a negative result is of use. Presuming a study is performed with sufficient power and scientific rigour, metagenomics has the potential to detect any microbe in a sample; therefore the lack of observed associations between ME/CFS and microbial entities would provide strong, albeit not conclusive, evidence that the origins of ME/CFS lie in non-infectious causes. However, it must be noted that metagenomics is not able to prove that a disease was instigated by a microbe if it has since been removed from the body site of investigation. Nevertheless, even if the causal microbe is no longer present, it may have changed the composition of the microbiome, by altering the presence or relative abundance of other microbes. Such changes could be detected by metagenomics and be used to diagnose and, in principle, treat the symptoms of ME/CFS, even if not the initial cause.

Read the rest of this Open Access article HERE.

Citation: Ruth R. Miller , Jennifer L. Gardy , Patrick Tang & David M. Patrick , Fatigue: Biomedicine, Health & Behavior (2013): A metagenomic approach to investigate the microbial causes of myalgic encephalomyelitis/chronic fatigue syndrome: moving beyond XMRV, Fatigue: Biomedicine, Health & Behavior DOI:10.1080/21641846.2013.812831



Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Vitamins and Supplements

Featured Products

FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ by ProHealth Vitamin D3 Extreme™ by ProHealth
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Sleep Like a Baby in Nature's Cradle Sleep Like a Baby in Nature's Cradle
Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
How I Found My Long-Lost Energy How I Found My Long-Lost Energy
Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing